<!DOCTYPE html SYSTEM "about:legacy-compat">
<html lang="en-US" class="no-js">
  <head>
    <meta charset="utf-8"/>
    <title>Chapter 01 Cancer Registry | Library of Maryland Regulations</title>
    <link rel="shortcut icon" href="/us/md/exec/_document/v2/images/favicons/favicon.ico"/>
    <!--Meta-->
    <meta http-equiv="X-UA-Compatible" content="IE=EDGE"/>
    <meta name="viewport" content="width=device-width, initial-scale=1"/>
    <meta name="format-detection" content="telephone=no"/>
    <meta name="HandheldFriendly" content="true"/>
    <meta itemprop="full-html" content="/us/md/exec/comar/10.14.01/index.full.html" data-document="href"/>
    <meta itemprop="toc-json" content="/us/md/exec/comar/10.14.01/index.json" data-document="href"/>
    <meta itemprop="parent-doc-url" content="/us/md/exec/comar" data-document="href"/>
    <meta itemprop="order" content="|10|14|01|"/>
    <meta itemprop="doc-type" content="container" data-document=""/>
    <meta itemprop="doc-num" content="01"/>
    <meta itemprop="ref-doc" content="Code of Maryland Regulations" data-document=""/>
    <meta itemprop="ref-path" content="10|14|01" data-document=""/>
    <!--OpenGraph-->
    <meta property="og:url" content="http://regs.maryland.gov//us/md/exec/comar/10.14.01"/>
    <meta property="og:type" content="article"/>
    <meta property="og:title" content="Chapter 01 Cancer Registry | Library of Maryland Regulations"/>
    <meta property="og:image" content="http://regs.maryland.gov//us/md/exec/_document/v2/images/og/og_image.png"/>
    <!--Progressive Web App-->
    <link rel="manifest" href="/manifest.json"/>
    <meta name="apple-mobile-web-app-capable" content="yes"/>
    <meta name="apple-mobile-web-app-status-bar-style" content="#0078EF"/>
    <meta name="apple-mobile-web-app-title" content="Library of Maryland Regulations"/>
    <meta name="theme-color" content="#0078EF"/>
    <meta name="apple-mobile-web-app-capable" content="yes"/>
    <meta name="mobile-web-app-capable" content="yes"/>
    <!--PWA icons-->
    <link rel="apple-touch-icon" sizes="180x180" href="/us/md/exec/_document/v2/images/favicons/apple-touch-icon.png"/>
    <link rel="apple-touch-icon-precomposed" sizes="60x60" href="/us/md/exec/_document/v2/images/favicons/apple-touch-icon-60x60-precomposed.png"/>
    <link rel="apple-touch-icon-precomposed" sizes="76x76" href="/us/md/exec/_document/v2/images/favicons/apple-touch-icon-76x76-precomposed.png"/>
    <link rel="apple-touch-icon-precomposed" sizes="152x152" href="/us/md/exec/_document/v2/images/favicons/apple-touch-icon-152x152-precomposed.png"/>
    <link rel="apple-touch-icon-precomposed" sizes="180x180" href="/us/md/exec/_document/v2/images/favicons/apple-touch-icon-180x180-precomposed.png"/>
    <link rel="mask-icon" href="/us/md/exec/_document/v2/images/favicons/safari-pinned-tab.svg" color="#0078EF"/>
    <link rel="icon" type="image/png" sizes="16x16" href="/us/md/exec/_document/v2/images/favicons/favicon-16x16.png"/>
    <link rel="icon" type="image/png" sizes="32x32" href="/us/md/exec/_document/v2/images/favicons/favicon-32x32.png"/>
    <link rel="icon" type="image/png" sizes="48x48" href="/us/md/exec/_document/v2/images/favicons/favicon-48x48.png"/>
    <!--Fonts-->
    <link href="/us/md/exec/_document/v2/biticons/biticons.css" type="text/css" rel="stylesheet" data-document=""/>
    <link href="/us/md/exec/_document/v2/fonts/public-sans/public-sans.css" type="text/css" rel="stylesheet" data-document=""/>
    <link href="/us/md/exec/_document/v2/fonts/merriweather/merriweather.css" type="text/css" rel="stylesheet" data-document=""/>
    <link href="/us/md/exec/_document/v2/fonts/roboto-mono/roboto-mono.css" type="text/css" rel="stylesheet" data-document=""/>
    <!--Document CSS-->
    <link href="/us/md/exec/_document/v2/styles/responsive.min.css" type="text/css" rel="stylesheet" media="screen" data-document=""/>
    <link href="/us/md/exec/_document/v2/styles/main.min.css" type="text/css" rel="stylesheet" media="screen" data-document=""/>
    <link href="/us/md/exec/_document/v2/styles/print.min.css" type="text/css" rel="stylesheet" media="print" data-document=""/>
    <link href="/_reader/styles/main.min.css" type="text/css" rel="stylesheet"/>
    <script src="/_reader/js/main.js" data-document=""> </script>
    <!--Links to resources that need to be prefetched-->
    <link rel="prefetch" href="/us/md/exec/comar/10.14.01/index.full.html" as="fetch"/>
    <link rel="prefetch" href="/index.json" as="fetch"/>
    <link rel="prefetch" href="/us/md/exec/comar/10.14.01/index.json" as="fetch"/>
  </head>
  <body>
    <div role="region" id="announcer" aria-live="polite" class="sr-only" aria-atomic="true" aria-label="Live messages">
      <p id="message"> </p>
    </div>
    <nav class="visually-hidden">
      <a href="#area__content" class="skip-link">Skip to main content</a>
    </nav>
    <div id="grid" class="ns__document__maryland-dsd">
      <header id="section__header" class="ns__document__maryland-dsd">
        <div id="section__header__inner" class="ns__document__maryland-dsd">
          <div id="area__logo" class="ns__document__maryland-dsd">
            <a href="/" class="logo" aria-label="Logo - Return to library home page">
              <img src="/us/md/exec/_document/v2/images/logo/logo.png" srcset="/us/md/exec/_document/v2/images/logo/logo.png 1x, /us/md/exec/_document/v2/images/logo/logo@2x.png 2x, /us/md/exec/_document/v2/images/logo/logo@3x.png 3x" alt="Library of Maryland Regulations logo"/>
            </a>
          </div>
          <div id="area__main_title" class="ns__document__maryland-dsd">
            <div class="h__library-logotype"><span class="line1">Library of</span> <span class="line2">Maryland Regulations</span></div>
          </div>
        </div>
      </header>
      <div id="section__content" class="ns__document__maryland-dsd">
        <div id="section__content__inner" class="ns__document__maryland-dsd">
          <section id="area__breadcrumbs" class="ns__document__maryland-dsd" role="region" aria-label="Breadcrumbs">
            <input type="checkbox" id="menu-trigger" class="menu-trigger" aria-label="Mobile menu toggler"/>
            <label for="menu-trigger">
              <span class="visually-hidden">Toggle mobile menu</span>
            </label>
            <nav role="navigation" aria-label="Breadcrumb navigation">
              <div class="h__ui">Navigation</div>
              <ul class="ancestors">
                <li data-search-path="library" data-search-heading="All Documents" class="no-indent">
                  <a href="/" title="Library of Maryland Regulations">Library of Maryland Regulations</a>
                </li>
                <li data-search-path="library|Code of Maryland Regulations" data-search-heading="" data-search-default="true" class="li__book-open">
                  <a href="/us/md/exec/comar" title="Code of Maryland Regulations">Code of Maryland Regulations</a>
                </li>
                <li data-search-path="library|Code of Maryland Regulations|10" data-search-heading="">
                  <a href="/us/md/exec/comar/10" title="Title 10 MARYLAND DEPARTMENT OF HEALTH">Title 10 MARYLAND DEPARTMENT OF HEALTH</a>
                </li>
                <li data-search-path="library|Code of Maryland Regulations|10|14" data-search-heading="">
                  <a href="/us/md/exec/comar/10.14" title="Subtitle 14 CANCER CONTROL">Subtitle 14 CANCER CONTROL</a>
                </li>
                <li data-search-path="library|Code of Maryland Regulations|10|14|01" data-search-heading="">
                  <span title="Chapter 01 Cancer Registry">Chapter 01 Cancer Registry</span>
                </li>
              </ul>
            </nav>
          </section>
          <main id="area__content" class="ns__document__maryland-dsd">
            <div class="h__document-title">Code of Maryland Regulations</div>
            <article class="content" role="document" data-ref-path="10|14|01">
              <div class="tuf-authenticate">
                <h1 class="h__toc" id="/us/md/exec/comar/10.14.01">Chapter 01 Cancer Registry</h1>
                <section class="line-group annotations">
                  <h2>Administrative History</h2>
                  <p>Effective date: September 28, 1992 (19:19 Md. R. 1707)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.14.01.01" title=".01 Scope.">Regulation .01</a> amended effective April 21, 1997 (24:8 Md. R. 616)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.14.01.02#B" title="">Regulation .02B</a> amended effective April 26, 1993 (20:8 Md. R. 723); April 21, 1997 (24:8 Md. R. 616); June 23, 2003 (30:12 Md. R. 788)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.14.01.04" title=".04 Cancer Control Goals of the State.">Regulation .04</a> amended effective April 21, 1997 (24:8 Md. R. 616)</p>
                  <p>Regulation .04C amended effective June 23, 2003 (30:12 Md. R. 788)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.14.01.05#B" title="">Regulation .05B</a> amended effective June 23, 2003 (30:12 Md. R. 788)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.14.01.06#B" title="">Regulation .06B</a>, D amended effective June 23, 2003 (30:12 Md. R. 788)</p>
                  <p>——————</p>
                  <p>Chapter revised effective March 22, 2010 (37:6 Md. R. 478)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.14.01.01" title=".01 Scope.">Regulation .01</a> amended effective January 13, 2011 (38:1 Md. R. 11); April 15, 2013 (40:7 Md. R. 611); February 27, 2017 (44:4 Md. R. 253)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.14.01.02#B" title="">Regulation .02B</a> amended effective January 13, 2011 (38:1 Md. R. 11); April 15, 2013 (40:7 Md. R. 611); February 27, 2017 (44:4 Md. R. 253)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.14.01.02-1" title=".02-1 Incorporation by Reference.">Regulation .02-1</a> adopted effective April 15, 2013 (40:7 Md. R. 611)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.14.01.02-1" title=".02-1 Incorporation by Reference.">Regulation .02-1</a> amended effective February 27, 2017 (44:4 Md. R. 253)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.14.01.05#C" title="">Regulation .05C</a> amended effective January 13, 2011 (38:1 Md. R. 11)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.14.01.06#B" title="">Regulation .06B</a> amended effective January 13, 2011 (38:1 Md. R. 11)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.14.01.07#G" title="">Regulation .07G</a> adopted effective April 15, 2013 (40:7 Md. R. 611)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.14.01.07#G" title="">Regulation .07G</a> amended effective February 27, 2017 (44:4 Md. R. 253)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.14.01.08#A" title="">Regulation .08A</a> amended effective January 13, 2011 (38:1 Md. R. 11)</p>
                  <h2>Authority</h2>
                  <p>Health-General Article, §§2-104, 18-104, 18-203 and 18-204, Annotated Code of Maryland; 42 U.S.C. §280(e)</p>
                </section>
                <h2 id="/us/md/exec/comar/10.14.01.01" data-order="|10|14|01|.01|" data-ref-path="10|14|01|.01" class="h__section">.01 Scope.</h2>
                <p>This chapter establishes a cancer registry within the Department, defines key terms, details the information to be contained in a cancer report, and specifies requirements of reporting facilities, nursing facilities, assisted living programs, and general hospice care programs. In addition, this chapter identifies requestors authorized to receive confidential data, allows a fee to be charged for data reports, and incorporates by reference the Maryland Cancer Registry Data Use Manual and Procedures (July 2016).</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/10.14.01.02" data-order="|10|14|01|.02|" data-ref-path="10|14|01|.02" class="h__section">.02 Definitions.</h2>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.01.02#A">A.</span> In this chapter, the following terms have the meanings indicated.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.01.02#B">B.</span> Terms Defined.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.01.02#B(1)">(1)</span> "Assisted living program" has the meaning stated in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.07.14.02#B" title="">COMAR 10.07.14.02B</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.01.02#B(2)">(2)</span> "Cancer registry" means a computerized system to register all cases of reportable human cancer or reportable human central nervous system (CNS) tumors of Maryland residents and nonresidents diagnosed or treated in Maryland.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.01.02#B(3)">(3)</span> "Cancer report" means a one-time abstract from one or more of the following documents maintained by a reporting facility, nursing facility, assisted living program, or general hospice care program of each new case of reportable human cancer or CNS tumor diagnosed or treated, and any other case of reportable human cancer or CNS tumor initially diagnosed or treated for time periods as designated by the Secretary:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.01.02#B(3)(a)">(a)</span> Medical record;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.01.02#B(3)(b)">(b)</span> Pathology report; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.01.02#B(3)(c)">(c)</span> Radiological report.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.01.02#B(4)">(4)</span> Case of a Reportable Human CNS Tumor.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.01.02#B(4)(a)">(a)</span> "Case of a reportable human CNS tumor" means an identified human tumor, irrespective of histologic type or behavior, occurring as a primary tumor in any of the following sites or subsites with International Classification of Diseases for Oncology, Third Edition (ICD-O-3) topography codes C70.0 — C72.9 and C75.1 — C75.3:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.01.02#B(4)(a)(i)">(i)</span> The brain;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.01.02#B(4)(a)(ii)">(ii)</span> The meninges;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.01.02#B(4)(a)(iii)">(iii)</span> The spinal cord;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.01.02#B(4)(a)(iv)">(iv)</span> The cauda equina;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.01.02#B(4)(a)(v)">(v)</span> A cranial nerve;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.01.02#B(4)(a)(vi)">(vi)</span> The pituitary gland;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.01.02#B(4)(a)(vii)">(vii)</span> The pineal gland; or</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.01.02#B(4)(a)(viii)">(viii)</span> The craniopharyngeal duct.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.01.02#B(4)(b)">(b)</span> “Case of a reportable human CNS tumor” includes all benign and uncertain behavior tumors of the CNS (ICD-10-CM Codes D18.02, D32.0 — D33.9, D35.2 — D35.4, D42.0 — D43.9, D44.3 — D44.5, Q85.00 — Q85.09 and D49.6, and all tumors of the CNS of benign and uncertain behavior with ICD-O-3 codes of “0” or “1”), which includes codes from:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.01.02#B(4)(b)(i)">(i)</span> The International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM); and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.01.02#B(4)(b)(ii)">(ii)</span> The International Classification of Diseases for Oncology, Third Edition (ICD-O-3).</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.01.02#B(5)">(5)</span> “Case of reportable human cancer” means the identification of a human cancer from the following list, which includes codes from the International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM) and the International Classification of Diseases for Oncology, Third Edition (ICD-O-3):</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.01.02#B(5)(a)">(a)</span> All malignant neoplasms with ICD-10-CM Codes C00 — C43.9, C44.00, C44.09, C44.10_, C44.19_, C44.20_, C44.29_, C44.30_, C44.39_, C44.40, C44.49, C44.50_, C44.59_, C44.60_, C44.69_, C44.70_, C44.79_, C44.80, C44.89, C44.90, C44.99, C45._ — C96._, or with ICD-O-3 behavior code of “3”, including genital skin cancer of the vagina, clitoris, vulva, prepuce, penis, and scrotum and excluding other sites of skin cancer with ICD-O-3 topography codes C44.0 — C44.9 with one of the following ICD-O-3 histologies:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.01.02#B(5)(a)(i)">(i)</span> M-8000 — 8005 Neoplasms, malignant, not otherwise specified of skin;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.01.02#B(5)(a)(ii)">(ii)</span> M-8010 — 8046 Epithelial carcinomas of skin;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.01.02#B(5)(a)(iii)">(iii)</span> M-8050 — 8084 Papillary and squamous cell carcinomas of skin (C44.02, C44.12_, C44.22_, C44.32_, C44.42, C44.52_, C44.62_, C44.72_, C44.82, C44.92); or</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.01.02#B(5)(a)(iv)">(iv)</span> M-8090 — 8110 Basal cell carcinomas (C44.01, C44.11_, C44.21_, C44.31_, C44.41, C44.51_, C44.61_, C44.71_, C44.81, C44.91);</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.01.02#B(5)(b)">(b)</span> All malignant neoplasms with the following ICD-10-CM codes where ICD-O-3 behavior is “3” and ICD-O-3 histologies are reported except as follows:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.01.02#B(5)(b)(i)">(i)</span> If there is evidence of multiple foci, lymph node involvement, or metastasis, C37 — Thymoma (M-8580);</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.01.02#B(5)(b)(ii)">(ii)</span> C7A.020 — Malignant carcinoid tumor of the appendix (M-8240);</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.01.02#B(5)(b)(iii)">(iii)</span> C54.1 — Endometrial stroma, low grade (M-8931);</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.01.02#B(5)(b)(iv)">(iv)</span> If there is evidence of multiple foci, lymph node involvement, or metastasis, D48.1 — Stromal Tumor of the digestive system (GIST 8639);</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.01.02#B(5)(b)(v)">(v)</span> D48.60 — Phylloides tumor (M-9020);</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.01.02#B(5)(b)(vi)">(vi)</span> D45 — Polycythema (M-9950);</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.01.02#B(5)(b)(vii)">(vii)</span> D47.Z9 — Plasmacytoma (M-9731, M-9734);</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.01.02#B(5)(b)(viii)">(viii)</span> D47.3 — Essential thrombocythemia (M-9962), D46.0, D46.1, D46.20, D46.21, D46A, D46B — Low grade myelodysplastic syndrome lesions (M-9980), D46.22 — High grade myelodysplastic syndrome lesions (M-9983), D46.C — Myelodysplastic syndrome with 5q deletion (M-9986), D469 — Myelodysplastic syndrome, unspecified (M-9975), D47.1 — Myelofibrosis with myeloid metaplasia (primary myelofibrosis) (M-9961), D47.Z1 — post-transplant lymphoproliferative disorder (M-9989), C94.40, C94.41, C94.42, D47.9, D47.Z9 — lympho and myeloproliferative disease (M-9960, M-9970);</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.01.02#B(5)(b)(ix)">(ix)</span> C88.2 — Alpha and gamma heavy chain disease (M-9762) or Franklin disease (M-9763);</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.01.02#B(5)(b)(x)">(x)</span> C88.0 — Waldenstrom macroglobulinemia (M-9761);</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.01.02#B(5)(b)(xi)">(xi)</span> D46.4 — Refractory anemia (M-9980); or</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.01.02#B(5)(b)(xii)">(xii)</span> D46.1 — Refractory anemia with ringed sideroblasts (M-9982), refractory anemia with excess blasts (M-9983), or refractory anemia with excess blasts in transformation (M-9984);</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.01.02#B(5)(c)">(c)</span> All cases of carcinoma in situ with ICD-10-CM Codes D00._ — D09.9, D47.Z2, D49.511 — D49.519, D49.59, D78.31 — D78.34, and D89.40 — D89.49, or with ICD-O-3 behavior code of “2”, including genital skin cancers of the vagina, clitoris, vulva, prepuce, penis, and scrotum and excluding other skin cancers with ICD-O-3 topography codes C44.0_ — C44.9_ with one of the following ICD-O-3 histologies:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.01.02#B(5)(c)(i)">(i)</span> M-8000 — 8005 Neoplasms, malignant, not otherwise specified of skin;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.01.02#B(5)(c)(ii)">(ii)</span> M-8010 — 8046 Epithelial carcinomas of skin;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.01.02#B(5)(c)(iii)">(iii)</span> M-8050 — 8084 Papillary and squamous cell carcinomas of skin; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.01.02#B(5)(c)(iv)">(iv)</span> M-8090 — 8110 Basal cell carcinomas; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.01.02#B(5)(d)">(d)</span> All cases of intraepithelial neoplasia with ICD-O-3 histology code of M-8077/2:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.01.02#B(5)(d)(i)">(i)</span> Including squamous intraepithelial neoplasia of the larynx (LIN), vagina (VAIN), vulva (VIN), and anus (AIN) (ICD-10-CM codes D02.0, D07.2, D07.1, and D01.3; and ICD-O-3 topography codes C52, C51, and C21._); and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.14.01.02#B(5)(d)(ii)">(ii)</span> Excluding squamous intraepithelial neoplasia of the cervix (CIN III) and glandular intraepithelial neoplasia of the prostate (PIN) (ICD-10-CM codes D06._ and D07.5; and ICD-O-3 topography codes C53 and C61.9).</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.01.02#B(6)">(6)</span> "Computerized file" means an electronic data file using software approved for use by the Secretary, containing complete cancer report information transferable to a master electronic database system maintained by the Department.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.01.02#B(7)">(7)</span> "Department" means the Maryland Department of Health or a designee.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.01.02#B(8)">(8)</span> "Freestanding ambulatory care facility" has the meaning stated in Health-General Article, §19-3B-01, Annotated Code of Maryland.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.01.02#B(9)">(9)</span> "Freestanding laboratory" means a facility, place, establishment, or institution which performs a laboratory examination for a person, authorized by law to request the examination, in connection with the diagnosis of a reportable human cancer or CNS tumor, and is licensed by the State pursuant to <a class="internal-link no-wrap" href="/us/md/exec/comar/10.10.03" title="Chapter 03 Medical Laboratories — Licenses">COMAR 10.10.03</a>, and:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.01.02#B(9)(a)">(a)</span> Not under the administrative control of a hospital; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.01.02#B(9)(b)">(b)</span> Under the administrative control of a hospital for a diagnosis of reportable human cancer or CNS tumor of a nonhospitalized patient.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.01.02#B(10)">(10)</span> “General hospice care program” has the meaning stated in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.07.21.02" title=".02 Definitions.">COMAR 10.07.21.02</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.01.02#B(11)">(11)</span> "Hospital" means a facility which is licensed by the State pursuant to <a class="internal-link no-wrap" href="/us/md/exec/comar/10.07.01" title="Chapter 01 Acute General Hospitals and Special Hospitals">COMAR 10.07.01</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.01.02#B(11-1)">(11-1)</span> “Maryland Cancer Registry Data Use Manual and Procedures” means the document that describes the Maryland cancer registry procedures for release of cancer data and that outlines the procedures to obtain both non-confidential aggregate data and confidential individual-level data.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.01.02#B(12)">(12)</span> "Nursing facility" has the meaning stated in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.07.02.01#B" title="">COMAR 10.07.02.01B</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.01.02#B(13)">(13)</span> "Physician" means an individual who:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.01.02#B(13)(a)">(a)</span> Practices medicine, as defined in <a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=14-101" title="">Health Occupations Article, §14-101, Annotated Code of Maryland</a>; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.01.02#B(13)(b)">(b)</span> Diagnoses or treats a case of reportable human cancer or a reportable human CNS tumor at a practice located in Maryland.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.01.02#B(14)">(14)</span> "Reporting facility" means any of the following:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.01.02#B(14)(a)">(a)</span> A hospital, freestanding laboratory, freestanding ambulatory care facility, or therapeutic radiological center; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.01.02#B(14)(b)">(b)</span> A physician who has care of or has diagnosed a case of reportable human cancer or reportable human CNS tumor for a nonhospitalized patient not otherwise reported.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.01.02#B(15)">(15)</span> "Secretary" means the Secretary of Health or a designee of the Secretary.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.01.02#B(16)">(16)</span> "Therapeutic radiological center" means a facility or institution:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.01.02#B(16)(a)">(a)</span> Performing radiological treatment for a person authorized by law to request the treatment in connection with a reportable human cancer or a reportable human CNS tumor; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.01.02#B(16)(b)">(b)</span> Licensed or registered by the State pursuant to <a class="internal-link no-wrap" href="/us/md/exec/comar/10.05.03" title="Chapter 03 Freestanding Major Medical Equipment Facilities">COMAR 10.05.03</a> and not under the administrative control of a hospital.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/10.14.01.02-1" data-order="|10|14|01|.02-1|" data-ref-path="10|14|01|.02-1" class="h__section">.02-1 Incorporation by Reference.</h2>
                <p>The Maryland Cancer Registry Data Use Manual and Procedures (Maryland Department of Health, July 2016) is incorporated by reference.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/10.14.01.03" data-order="|10|14|01|.03|" data-ref-path="10|14|01|.03" class="h__section">.03 Establishment of a Cancer Registry.</h2>
                <p>There is a cancer registry established within the Department, whose purpose is to collect reportable human cancer data and reportable human CNS tumor data to further the cancer control goals of the State.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/10.14.01.04" data-order="|10|14|01|.04|" data-ref-path="10|14|01|.04" class="h__section">.04 Cancer Control Goals of the State.</h2>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.01.04#A">A.</span> The cancer control goals of the State are to reduce the incidence and mortality of reportable human cancer and reportable human CNS tumors and racial, ethnic, gender, age, and geographic disparities in reportable human cancer and CNS tumor incidence and mortality in Maryland, by:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.01.04#A(1)">(1)</span> Advancing the understanding of reportable human cancer and reportable human CNS tumor demographics;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.01.04#A(2)">(2)</span> Describing reportable human cancer and reportable human CNS tumor sources, causes, risk factors, preventive measures, diagnostic tests, screening tests, treatment, and survival; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.01.04#A(3)">(3)</span> Evaluating the cost, quality, efficacy, and appropriateness of diagnostic, therapeutic, rehabilitative, and preventive services and programs related to reportable human cancer and reportable human CNS tumors.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.01.04#B">B.</span> Research that will further the cancer control goals of the State is research whose protocols have been reviewed by Department staff who have found that the research will:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.01.04#B(1)">(1)</span> Advance scientific knowledge or advance knowledge of clinical practice related to cancer;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.01.04#B(2)">(2)</span> Have approaches, aims, and methods that will allow the researcher to perform descriptive analyses or test hypotheses;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.01.04#B(3)">(3)</span> Have one or more investigators who have training and experience with the approaches and methods; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.01.04#B(4)">(4)</span> Be conducted in a scientific environment likely to contribute to the success of the research.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/10.14.01.05" data-order="|10|14|01|.05|" data-ref-path="10|14|01|.05" class="h__section">.05 Content of a Cancer Report.</h2>
                <p>A cancer report shall contain the following information, using the standard nomenclature contained in the North American Association of Central Cancer Registries' Standards for Cancer Registries, Volume II, Data Standards and Data Dictionary:</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.01.05#A">A.</span> Reasonably obtained patient demographic information, including risk factors;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.01.05#B">B.</span> Information on the industrial or occupational history of an individual with cancer, to the extent such information is available;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.01.05#C">C.</span> Relevant information on the:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.01.05#C(1)">(1)</span> Initial diagnosis, including the date of the diagnosis;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.01.05#C(2)">(2)</span> Initial treatment;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.01.05#C(3)">(3)</span> Extent of the disease by the end of the first hospitalization; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.01.05#C(4)">(4)</span> Extent of the disease within 2 months of diagnosis, if the information is available to the reporting facility, nursing facility, assisted living program, or general hospice care program;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.01.05#D">D.</span> Facility and other provider identification information; and</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.01.05#E">E.</span> Other requirements as considered necessary by the Secretary.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/10.14.01.06" data-order="|10|14|01|.06|" data-ref-path="10|14|01|.06" class="h__section">.06 Reporting Requirements.</h2>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.01.06#A">A.</span> A reporting facility shall submit a:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.01.06#A(1)">(1)</span> Cancer report to the Secretary in a computerized file containing standard information required by the Secretary;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.01.06#A(2)">(2)</span> Computerized file not less than quarterly; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.01.06#A(3)">(3)</span> Completed report of any new individual case of a reportable human cancer or reportable human CNS tumor not later than 6 months after diagnosis or treatment.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.01.06#B">B.</span> A nursing facility, an assisted living program, or a general hospice care program shall submit a cancer report containing information that is under the control of the facility to the Secretary if the Secretary requests a cancer report on a patient who has been a resident of the nursing facility, assisted living program, or general hospice care program.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/10.14.01.07" data-order="|10|14|01|.07|" data-ref-path="10|14|01|.07" class="h__section">.07 Confidentiality of Cancer Reports.</h2>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.01.07#A">A.</span> Information obtained under this chapter is not a medical record under Health-General Article, §4-301, Annotated Code of Maryland, but is subject to the confidentiality requirements of Health-General Article, §§4-101 — 4-103, Annotated Code of Maryland.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.01.07#B">B.</span> The Secretary may release confidential data to:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.01.07#B(1)">(1)</span> An institution or individual researcher for medical, epidemiological, health care, or other cancer-related or CNS tumor-related research approved by the Secretary and the Department's Institutional Review Board (IRB) in order to further the cancer control goals of the State set forth in <a class="internal-link " href="/us/md/exec/comar/10.14.01.04" title=".04 Cancer Control Goals of the State.">Regulation .04 of this chapter</a>;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.01.07#B(2)">(2)</span> A reporting facility which:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.01.07#B(2)(a)">(a)</span> Routinely submits information on cases of reportable human cancer or reportable human CNS tumors to the cancer registry;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.01.07#B(2)(b)">(b)</span> Has been formally accepted as a participant in the cancer registry system; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.01.07#B(2)(c)">(c)</span> Requests data relating to patients reported by the facility;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.01.07#B(3)">(3)</span> An out-of-State cancer registry or cancer control agency which requests routine data if the:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.01.07#B(3)(a)">(a)</span> Patient is a resident of the other state; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.14.01.07#B(3)(b)">(b)</span> Other state has authority to provide equivalent information on Maryland residents to this State;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.01.07#B(4)">(4)</span> Each county health officer and the Baltimore City Commissioner of Health; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.01.07#B(5)">(5)</span> Another governmental agency performing its lawful duties pursuant to State or federal law.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.01.07#C">C.</span> The Secretary may release confidential information, subject to:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.01.07#C(1)">(1)</span> A determination by the Secretary that a recipient of the information disclosed will maintain the confidentiality of the disclosed information; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.01.07#C(2)">(2)</span> An agreement signed by the Secretary and by the recipient of the confidential information that the recipient of the information will maintain the confidentiality of the disclosed information.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.01.07#D">D.</span> The Secretary shall release confidential data to a requestor in response to a written request only, in accordance with Health-General Article, §§4-101 and 4-102, Annotated Code of Maryland.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.01.07#E">E.</span> A reporting facility that in good faith submits a cancer report to the Secretary is not liable in any cause of action arising from the submission of the cancer report to the Secretary.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.01.07#F">F.</span> The use or publication of any statistics, information, or other material that summarizes or refers to confidential records in the aggregate, without disclosing the identity of any person who is the subject of the confidential record is not subject to the provisions of Health-General Article, §4-102, Annotated Code of Maryland.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.01.07#G">G.</span> The Secretary shall release cancer data in accordance with the procedures outlined in the Maryland Cancer Registry Data Use Manual and Procedures.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/10.14.01.08" data-order="|10|14|01|.08|" data-ref-path="10|14|01|.08" class="h__section">.08 Authority and Requirements of the Secretary.</h2>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.01.08#A">A.</span> To assure compliance by a reporting facility, nursing facility, assisted living program, or general hospice care program with <a class="internal-link " href="/us/md/exec/comar/10.14.01.05" title=".05 Content of a Cancer Report.">Regulation .05 of this chapter</a>, the Secretary may, upon advance notice, inspect a representative sample of medical records, pathology reports, or radiological reports maintained by the facility of cases of reportable human cancer and reportable human CNS tumors.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.01.08#B">B.</span> The Secretary may charge a reasonable fee to cover the cost of providing data reports to appropriate requestors, as allowed by <a class="internal-link no-wrap" href="/us/md/exec/comar/10.01.08.04" title=".04 Fees.">COMAR 10.01.08.04</a>. All applicable fees shall be paid in full in advance of filling the request.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.01.08#C">C.</span> After receiving all necessary information to support a request to release cancer registry data, the Secretary shall act in a timely manner and decide on the request with one of the following outcomes:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.01.08#C(1)">(1)</span> Final approval;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.01.08#C(2)">(2)</span> Interim approval, if the request has been accepted with one or more conditions which shall be met before final approval is granted; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.14.01.08#C(3)">(3)</span> Disapproval.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.01.08#D">D.</span> The Secretary, in accordance with <a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gsg&amp;section=2-1246" title="">State Government Article, §2-1246, Annotated Code of Maryland</a>, shall submit an annual report to the Governor and General Assembly on the activities of the cancer registry, including use of cancer registry data.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.14.01.08#E">E.</span> Nothing in this chapter is intended to limit or otherwise restrict the Secretary from obtaining cancer report information on Maryland residents from sources located either inside or outside the State.</p>
                <hr class="section-separator" aria-hidden="true"/>
              </div>
            </article>
          </main>
          <nav id="area__navigation_mini" class="ns__document__maryland-dsd" aria-label="Previous and next article links">
            <section>
              <a href="/us/md/exec/comar/10.14" aria-label="Subtitle 14 CANCER CONTROL">
                <div class="h__ui">Previous</div>
                <span>Subtitle 14 CANCER CONTROL</span>
              </a>
            </section>
            <section>
              <a href="/us/md/exec/comar/10.14.02" aria-label="Chapter 02 Reimbursement for Breast and Cervical Cancer Diagnosis and Treatment">
                <div class="h__ui">Next</div>
                <span>Chapter 02 Reimbursement for Breast and Cervical Cancer Diagnosis and Treatment</span>
              </a>
            </section>
          </nav>
        </div>
      </div>
      <footer id="section__footer" class="ns__document__maryland-dsd">
        <div id="section__footer__inner" class="ns__document__maryland-dsd">
          <div id="area__footer__content" class="ns__document__maryland-dsd">
<p>This version of the laws and codes on this website is licensed under the <a href="https://creativecommons.org/licenses/by-nc-sa/4.0/">CC BY-NC-SA 4.0</a> license with copyright held by the State of Maryland.</p><p>This version of the laws and codes on this website will be dedicated to the public domain under the <a href="https://creativecommons.org/publicdomain/zero/1.0/">CC0 1.0</a> license 180 days after publication.</p>
<p>
      Please do not scrape. Instead, bulk download the CC BY-NC-SA-4.0 <a href="https://github.com/maryland-dsd/law-html">HTML</a> or <a href="https://github.com/maryland-dsd/law-xml">XML</a> or CC0 <a href="https://github.com/maryland-dsd/law-html-cc0">HTML</a> or <a href="https://github.com/maryland-dsd/law-xml-cc0">XML</a>.
    </p><p>Powered by the non-profit <a href="https://www.openlawlib.org/">Open Law Library</a>.</p></div>
        </div>
      </footer>
    </div>
    <!--Piwik analytics-->
    <noscript>
      <img src="/_analytics/pixel.png" style="border:0;" alt=""/>
    </noscript>
  </body>
</html>
